149 related articles for article (PubMed ID: 38394737)
1. Ligustilide inhibits Purkinje cell ferritinophagy via the ULK1/NCOA4 pathway to attenuate valproic acid-induced autistic features.
Zhou L; Jiang P; Zhao L; Fei X; Tang Y; Luo Y; Gong H; Wang X; Li X; Li S; Zhang C; Yang H; Fan X
Phytomedicine; 2024 Apr; 126():155443. PubMed ID: 38394737
[TBL] [Abstract][Full Text] [Related]
2. Retinoic acid supplementation ameliorates motor incoordination via RARα-CBLN2 in the cerebellum of a prenatal valproic acid-exposed rat autism model.
Yuan B; Luo L; Hu C; Lin F; Yang T; Chen J; Li T
Neurosci Lett; 2023 Jul; 809():137316. PubMed ID: 37247722
[TBL] [Abstract][Full Text] [Related]
3. Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats.
Mirza R; Sharma B
Brain Res Bull; 2019 Apr; 147():36-46. PubMed ID: 30769127
[TBL] [Abstract][Full Text] [Related]
4. Vitamin A supplementation ameliorates prenatal valproic acid-induced autism-like behaviors in rats.
Liu Z; Wang J; Xu Q; Wu Z; You L; Hong Q; Zhu J; Chi X
Neurotoxicology; 2022 Jul; 91():155-165. PubMed ID: 35594946
[TBL] [Abstract][Full Text] [Related]
5. [Mechanism of valproic acid-induced dendritic spine and synaptic impairment in the prefrontal cortex for causing core autistic symptoms in mice].
Wang F; Wang L; Xiong Y; Deng J; Lü M; Tang B; Zhang X; Li Y
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jan; 42(1):101-107. PubMed ID: 35249876
[TBL] [Abstract][Full Text] [Related]
6. The Notch signaling pathway inhibitor Dapt alleviates autism-like behavior, autophagy and dendritic spine density abnormalities in a valproic acid-induced animal model of autism.
Zhang Y; Xiang Z; Jia Y; He X; Wang L; Cui W
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Aug; 94():109644. PubMed ID: 31075347
[TBL] [Abstract][Full Text] [Related]
7. The histamine H3R antagonist DL77 attenuates autistic behaviors in a prenatal valproic acid-induced mouse model of autism.
Eissa N; Jayaprakash P; Azimullah S; Ojha SK; Al-Houqani M; Jalal FY; Łażewska D; Kieć-Kononowicz K; Sadek B
Sci Rep; 2018 Aug; 8(1):13077. PubMed ID: 30166610
[TBL] [Abstract][Full Text] [Related]
8. Vitamin A ameliorates valproic acid-induced autism-like symptoms in developing zebrafish larvae by attenuating oxidative stress and apoptosis.
Wang J; Zou L; Jiang P; Yao M; Xu Q; Hong Q; Zhu J; Chi X
Neurotoxicology; 2024 Mar; 101():93-101. PubMed ID: 38191030
[TBL] [Abstract][Full Text] [Related]
9. Subchronic treatment of donepezil rescues impaired social, hyperactive, and stereotypic behavior in valproic acid-induced animal model of autism.
Kim JW; Seung H; Kwon KJ; Ko MJ; Lee EJ; Oh HA; Choi CS; Kim KC; Gonzales EL; You JS; Choi DH; Lee J; Han SH; Yang SM; Cheong JH; Shin CY; Bahn GH
PLoS One; 2014; 9(8):e104927. PubMed ID: 25133713
[TBL] [Abstract][Full Text] [Related]
10. Puerarin attenuates valproate-induced features of ASD in male mice via regulating Slc7a11-dependent ferroptosis.
Jiang P; Zhou L; Zhao L; Fei X; Wang Z; Liu T; Tang Y; Li D; Gong H; Luo Y; Li S; Yang H; Liao H; Fan X
Neuropsychopharmacology; 2024 Feb; 49(3):497-507. PubMed ID: 37491673
[TBL] [Abstract][Full Text] [Related]
11. Nrf2 activator, sulforaphane ameliorates autism-like symptoms through suppression of Th17 related signaling and rectification of oxidant-antioxidant imbalance in periphery and brain of BTBR T+tf/J mice.
Nadeem A; Ahmad SF; Al-Harbi NO; Attia SM; Bakheet SA; Ibrahim KE; Alqahtani F; Alqinyah M
Behav Brain Res; 2019 May; 364():213-224. PubMed ID: 30790585
[TBL] [Abstract][Full Text] [Related]
12. Size anomaly and alteration of GABAergic enzymes expressions in cerebellum of a valproic acid mouse model of autism.
Ma SY; Kwan KM
Behav Brain Res; 2022 Jun; 428():113896. PubMed ID: 35436531
[TBL] [Abstract][Full Text] [Related]
13. Selenium inhibits ferroptosis and ameliorates autistic-like behaviors of BTBR mice by regulating the Nrf2/GPx4 pathway.
Wu H; Luan Y; Wang H; Zhang P; Liu S; Wang P; Cao Y; Sun H; Wu L
Brain Res Bull; 2022 Jun; 183():38-48. PubMed ID: 35227767
[TBL] [Abstract][Full Text] [Related]
14. Vitamin A supplementation ameliorates motor incoordination via modulating RORα in the cerebellum in a valproic acid-treated rat autism model with vitamin A deficiency.
Wang S; Liu H; Cheng B; Wu Q; Li L; Yang T; Hou N; Li T
Neurotoxicology; 2021 Jul; 85():90-98. PubMed ID: 33991534
[TBL] [Abstract][Full Text] [Related]
15. Assessment of behavioral, morphological and electrophysiological changes in prenatal and postnatal valproate induced rat models of autism spectrum disorder.
Fereshetyan K; Chavushyan V; Danielyan M; Yenkoyan K
Sci Rep; 2021 Dec; 11(1):23471. PubMed ID: 34873263
[TBL] [Abstract][Full Text] [Related]
16. Chronic inhibition of astrocytic aquaporin-4 induces autistic-like behavior in control rat offspring similar to maternal exposure to valproic acid.
Davoudi S; Rahdar M; Hosseinmardi N; Behzadi G; Janahmadi M
Physiol Behav; 2023 Oct; 269():114286. PubMed ID: 37402416
[TBL] [Abstract][Full Text] [Related]
17. Sodium phenylbutyrate reduces repetitive self-grooming behavior and rescues social and cognitive deficits in mouse models of autism.
Ryu YK; Park HY; Go J; Choi DH; Choi YK; Rhee M; Lee CH; Kim KS
Psychopharmacology (Berl); 2021 Jul; 238(7):1833-1845. PubMed ID: 33723660
[TBL] [Abstract][Full Text] [Related]
18. Thymol improves autism-like behaviour in VPA-induced ASD rats through the Pin1/p38 MAPK pathway.
Xiong Y; Chen J; Lv M; Wang F; Zhang H; Tang B; Li Y
Int Immunopharmacol; 2023 Apr; 117():109885. PubMed ID: 36842231
[TBL] [Abstract][Full Text] [Related]
19. Epothilone D Modulates Autism-like Behaviors in the BTBR Mouse Model of Autism Spectrum Disorder.
Zhao M; Chang Q; Yang H; Wang M; Liu Y; Lv N; Lei Q; Wei H
Neuroscience; 2022 May; 490():171-181. PubMed ID: 35227832
[TBL] [Abstract][Full Text] [Related]
20. Postnatal baicalin ameliorates behavioral and neurochemical alterations in valproic acid-induced rodent model of autism: The possible implication of sirtuin-1/mitofusin-2/ Bcl-2 pathway.
Elesawy RO; El-Deeb OS; Eltokhy AK; Arakeep HM; Ali DA; Elkholy SS; Kabel AM
Biomed Pharmacother; 2022 Jun; 150():112960. PubMed ID: 35447549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
